Literature DB >> 2253200

Inherent sensitivity and induced resistance to chemotherapeutic drugs and irradiation in human cancer cell lines: relationship to mutation frequencies.

C N Parris1, M C Walker, J R Masters, C F Arlett.   

Abstract

Metastatic nonseminomatous testicular germ cell tumors are curable using combination chemotherapy in approximately 80% of patients. In contrast, most other patients with other types of cancer either present with or acquire drug-resistant disease following chemotherapy. Cell lines derived from testis tumors retain hypersensitivity to both drugs and radiation in vitro, thus providing a model system with which to investigate the genetic basis of hypersensitivity to these agents. This study compared the spontaneous and both ethyl methanesulfonate- and cisplatin-induced frequencies of mutation of 6-thioguanine resistance in 3 human bladder and 3 testis tumor cell lines and a bladder and a testis cell line with cisplatin resistance induced in vitro. The two tumor types showed similar frequencies of both spontaneous and induced mutation frequencies at this locus. Therefore, we failed to provide evidence for the hypothesis that the curability of testis tumors is associated with a low frequency of mutation to drug resistance.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2253200

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

Review 1.  Apoptosis induced by anticancer drugs.

Authors:  J A Hickman
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

2.  O6-alkylguanine-DNA-alkyltransferase activity and nitrosourea sensitivity in human cancer cell lines.

Authors:  M C Walker; J R Masters; G P Margison
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640

3.  Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell lines.

Authors:  M W Sark; H Timmer-Bosscha; C Meijer; D R Uges; W J Sluiter; W H Peters; N H Mulder; E G de Vries
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

4.  Blood T cell diversity associated with the prognosis of advanced non-small cell lung carcinoma treated with first-line pemetrexed based chemotherapy.

Authors:  Li Qian; Zhang Zhaohui; Xu Yaping; Liu Zhentian; Liu Zhentao; Wang Qiqi; Gu Yangchun; Liu Yan'e; Yin Wencheng; Yi Fumei; Yao Yanhong; Cao Baoshan; Liang Li
Journal:  Thorac Cancer       Date:  2021-02-24       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.